University of Illinois at Chicago, United States
Amgen (Consultant/Advisory Board)Cellgene (Consultant/Advisory Board)Janssen (Consultant/Advisory Board)
Comparison of Denosumab versus Bisphosphonates on Progression-free and Overall Survival in Newly Diagnosed Multiple Myeloma: A New User, Active Comparator Analysis of Real-World Data
Sunday, August 28, 20222:15 PM – 2:30 PM CEST
